Clinical Trial Update: Safety, Pharmacokinetic (PK), Pharmcodynamic (PD), and Drug-Drug Interaction of PLX3397 in Patients With Rheumatoid Arthritis Who Are Receiving Methotrexate [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety, pharmacokinetics, pharmacodynamics, and drug-drug interactions of PLX3397 in rheumatoid arthritis patients taking methotr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• PLX3397 (PLX3397)

Snippet

Sponsor: Plexxikon | Conditions: Rheumatoid Arthritis | Phase 1 | Status: WITHDRAWN